Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/895   
Active ingredient: Hydroxy-propyl-beta-cyclodextrin
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: Medical Need Europe AB
Teatergatan 3, 111 48 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/09/2011 Orphan designation EMA/OD/033/11 (2011)6282 of 30/08/2011
09/03/2015 Transfer of orphan designation EMA/OD/033/11/T01 (2015)1600 of 05/03/2015